Smart Inhalers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Smart Inhalers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global smart inhalers market size reached US$ 204.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 750.3 Million by 2028, exhibiting a growth rate (CAGR) of 23.5% during 2023-2028.

Smart inhalers are respiratory inhalers that can monitor adherence, send dosage reminders, offer access to readily shareable information via Bluetooth, and record the time, date and location of each dosage administered accurately. They can also help improve compliance with therapy, increase patient involvement and motivation in controlling symptoms, and provide reports about environmental and weather conditions that may affect their chest. Due to the growing prevalence of asthma and chronic obstructive pulmonary diseases (COPD), there is a rise in the demand for smart inhalers across the globe.

Smart Inhalers Market Trends:
Due to a rise in air pollution levels worldwide, there is a significant increase in the number of patients with chronic respiratory diseases (CRDs), lung cancer, chronic bronchitis, and acute lower respiratory infections (ALRI). This represents one of the key factors propelling the growth of the market. Moreover, the efficacy of conventional inhalers can be negatively impacted by incorrect inhaler techniques and poor adherence, which may result in the progression of patients’ condition. However, smart inhalers can address the challenges of patients and healthcare professionals in the management of these diseases using digital features designed to connect with mobile applications for monitoring medication schedules and subsequent dosing. Additionally, they can alert patients and clinicians when symptoms require specific action and facilitate a shift to better self-care. This, coupled with recent advances in smart inhaler technology, which allow feedback to users on their inhaler technique and the calculation of the correct level of adherence, is driving the market. Besides this, the increasing awareness about the benefits of using smart inhalers among patients is projected to augment the overall sales and profitability.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global smart inhalers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

Inhalers
Dry Powdered Inhaler
Metered Dose Inhaler
Nebulizers

Breakup by Indication:

Asthma
Chronic Obstructive Pulmonary Disease (COPD)

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Stores

Breakup by Region:


North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Adherium Limited, AptarGroup Inc., AstraZeneca plc, Boehringer Ingelheim, Cognita Labs, GlaxoSmithKline plc, Novartis AG, OPKO Health Inc., Propeller Health (ResMed), Sensirion AG, Teva Pharmaceutical Industries Ltd. and Vectura Group Limited (Philip Morris International Inc.).

Key Questions Answered in This Report

1. What was the size of the global smart inhalers market in 2022?
2. What is the expected growth rate of the global smart inhalers market during 2023-2028?
3. What has been the impact of COVID-19 on the global smart inhalers market?
4. What are the key factors driving the global smart inhalers market?
5. What is the breakup of the global smart inhalers market based on the product?
6. What is the breakup of the global smart inhalers market based on the indication?
7. What is the breakup of the global smart inhalers market based on distribution channel?
8. What are the key regions in the global smart inhalers market?
9. Who are the key players/companies in the global smart inhalers market?


1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3Executive Summary
4Introduction
4.1Overview
4.2Key Industry Trends
5Global Smart Inhalers Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6Market Breakup by Product
6.1Inhalers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Dry Powdered Inhaler
6.1.2.2 Metered Dose Inhaler
6.1.3 Market Forecast
6.2Nebulizers
6.2.1 Market Trends
6.2.2 Market Forecast
7Market Breakup by Indication
7.1Asthma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Chronic Obstructive Pulmonary Disease (COPD)
7.2.1 Market Trends
7.2.2 Market Forecast
8Market Breakup by Distribution Channel
8.1Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9Market Breakup by Region
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10SWOT Analysis
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11Value Chain Analysis
12Porters Five Forces Analysis
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13Price Analysis
14Competitive Landscape
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.13M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Adherium Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3AptarGroup Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4AstraZeneca plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5Boehringer Ingelheim
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6Cognita Labs
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7GlaxoSmithKline plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9OPKO Health Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10Propeller Health (ResMed)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11Sensirion AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12Teva Pharmaceutical Industries Ltd.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13Vectura Group Limited (Philip Morris International Inc.)
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings